1-844-762-9522 info@rdxbioscience.com

Press Releases

RDx BioScience In The News
Show more

RDx BioScience Examines the Role of Pharmacogenomic Testing to Lower Medication Costs and Overall Healthcare Expenditures at New York Health Forum

May 23, 2018|
  “Collaboration for Success: Multi-Regional Clinical Development,” May 25, 12:30-5...
Read More
Show more

RDx BioScience Recommends Pharmacogenetic Testing to Improve Clinical Outcomes, Lower Healthcare Costs for Self-Insured Employers

April 25, 2018|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high quality laboratory and genomic testing, and...
Read More
Show more

RDx BioScience& MedTek21 Collaboration Delivers Continuous Genomics-Based Medication Monitoring, Improves Outcomes, Cuts Costs for Payers and Plan Sponsors

April 18, 2018|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high quality laboratory and genomic testing, and...
Read More
Show more

RDx BioScience Highlights Impact of Drug Abuse in the Workplace, Offers Employment Drug Testing as Powerful Risk Mitigation Tool

January 11, 2018|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing...
Read More
Show more

RDx BioScience Announces Appointments: Preeminent Scientist as Laboratory Director, and Pain and Opioid Prescribing Expert as Director of Provider Relations

November 13, 2017|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing...
Read More
Show more

RDx BioScience Supports President Trump’s Declaration: Opioid Crisis is a Public Health Emergency

October 27, 2017|
Calls for expanded physician prescribing education   President Trump’s designation...
Read More
Show more

RDx BioScience Recommends Genomic Testing to Assess Cancer Risks: Employers & Payers Optimize Clinical Outcomes, Improve Member Satisfaction

October 23, 2017|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing, and evidence-based...
Read More
Show more

RDx BioScience Examines the Future of Alternative Payment Models for Addiction Medicine at N.Y. State Conference of Alcoholism & Substance Abuse Providers

September 18, 2017|
KENILWORTH, N.J.--RDx BioScience(RDx), providers of high-quality laboratory and genomic testing,...
Read More
Show more

Nation’s Opioid Epidemic, Increase Mandatory Prescriber Education Underwriters of educational grant for a Mandatory Prescriber Education Course in New York state, Tenet seeks to replicate program

August 3, 2017|
Industry Leader Tenet Diagnostics Supports Opioid Commission’s Initiative to Reverse KENILWORTH, N.J.--As an industry leader,...
Read More
Show more

RDx BioScience Appoints Scott Howell, MD, MPH & TM, CPE, Expert in Clinical Outcomes, Economics and Public Health, as New Chief Medical Officer

July 26, 2017|
KENILWORTH, N.J.--RDx BioScience (RDx), providers of high-quality laboratory and genomic testing and evidence-based research designed...
Read More
Show more

RDx BioScience Diagnostics Highlights Importance of Pharmacogenomics in Preventing Adverse Drug Reactions, Mitigating Opioid Addiction and Death

July 6, 2017|
KENILWORTH, N.J.--RDx BioScience (RDx) providers of high-quality laboratory and genomic...
Read More
Show more

RDx BioScience Teams Up with OpiSafe, Offers Physicians Optimal Approach for Prescribing, Managing and Monitoring Opioid Abuse

June 12, 2017|
KENILWORTH, N.J.-- RDx BioScience (RDx), providers of high-quality laboratory and...
Read More
Show more

RDx BioScience Supports New York Pain Society Annual Meeting, Provides Educational Grant Supporting Mandatory Prescriber Education Course

March 29, 2017|
KENILWORTH, N.J.-- RDx BioScience, (RDx) providers of high-quality laboratory and...
Read More
Share This